Home » View latest Theophylline Tenders from India

View latest Theophylline Tenders from India

TendersOnTime provides latest updates on Indian Theophylline Tenders from various state and central government tendering authorities. The information on Theophylline online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Supply of Theophylline Dc Granules 12W/W-2000 Kg

TOT Ref No.: 100248723

Deadline: 30 Apr 2024

Country: India

Etofylline 231Mg Plus Theophylline 69Mg Sr Tab

TOT Ref No.: 100360752

Deadline: 30 Apr 2024

Country: India

Inj. Etophylline 84.7 Mg + Theophylline 25.3 Mg Per Ml, 2 Ml Ampoules.

TOT Ref No.: 99280290

Deadline: 08 May 2024

Country: India

Supply of Theophylline SR 400 mg Tab No Qty 1200 At Panaji

TOT Ref No.: 99528198

Deadline: 30 Apr 2024

Country: India

Theophylline 50.6Mg Plus Etophyllin 169.4Mg Inj 2Ml Amp

TOT Ref No.: 100001312

Deadline: 26 Apr 2024

Country: India

Tab Etophyllin and Theophylline Sr, Qty: 1500 No, (BOQ Item #14)

TOT Ref No.: 100338878

Deadline: 13 May 2024

Country: India

Supply Of TAB ETOPHYLLINE WITH THEOPHYLLINE 100MGTAB 1X1 Qty:-80000 At Hubballi

TOT Ref No.: 98418585

Deadline: 08 May 2024

Country: India

Inj Etofylline Theophylline 2 Ml, Qty: 1 EACH, (BOQ Item #44)

TOT Ref No.: 99997156

Deadline: 04 May 2024

Country: India

Crs/Tpty Drug (Ph No.:21020) Etophylline 84.7 Mg + Theophylline 25.3 Mg Inj

TOT Ref No.: 100024397

Deadline: 26 Apr 2024

Country: India

Tab Etophyllineand Theophylline 150 Mg, Qty: 600 No, (BOQ Item #9)

TOT Ref No.: 100311265

Deadline: 13 May 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.